According to a new report from Intel Market Research, the global Recombinant Human Serum Albumin Market was valued at USD 77.7 million in 2024 and is projected to grow from USD 83.8 million in 2025 to USD 129 million by 2034, exhibiting a robust CAGR of 7.8% during the forecast period. Growth is driven by increasing demand for biologics and biosimilars, stringent regulatory requirements for...
Indonesia
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek